New hope to ditch steroids for painful muscle condition
NCT ID NCT05533125
Summary
This study tested if a drug called Rituximab could help people newly diagnosed with polymyalgia rheumatica (PMR) achieve remission without needing long-term steroid treatment. Steroids are the standard treatment but can have serious side effects. The trial compared Rituximab against a placebo to see if it allowed patients to safely stop steroids and stay symptom-free for a full year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYMYALGIA RHEUMATICA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sint Maartensklineik
Ubbergen, Gelderland, 6574 NA, Netherlands
Conditions
Explore the condition pages connected to this study.